From Rory........... Thank you Roni. I fully expected to

New Post Public Reply Private Reply Replies (5) Message Board
Roni1 Natural Treasures #8440
723
From Rory...........

Thank you Roni. I fully expected to take a lot of heat for the back-up strategy around the reverse split and I acknowledge that a RS appears to contradict directly my prior comments about doing a RS. It does. And I intend to own that and explain my thinking in Monday’s SHAC video, which thinking incorporates the benefit of some of the greatest business minds with whom I’ve consulted on these issues, all of whom are nFusz shareholders, Board members and Advisory Board members, and all of whom, as shareholders, have their interests aligned with yours and all other shareholders. And most importantly – all of whom, including me and my team, bear the same consequences of our decisions that you do. So, none of our decisions are made lightly. Quite the contrary. We have one goal. Just one. Increase shareholder value. Everything we do must ultimately contribute to that goal. And every decision we make is made with that goal in mind. That doesn’t mean that shareholder value and corresponding stock price is a straight up arrow. There will be ups and downs, peaks and valleys, and accumulation opportunities along the way for those with vision. For many, especially OTC day traders, it’s impossible to see the forest through the trees. Some because they don’t see the long-term vision being executed, some because they don’t understand it, and others because they are sheep easily scared out of their shares by people whose interests are not aligned with theirs, and in some cases, as we now know, by people who don’t even own the stock and are paid to scare people out of their shares by unsavory characters who make a living preying on others in violation of the law. This is the unfortunate side of the OTC. I do not mean to disparage the many companies who trade on the OTC that have honest, legitimate thriving businesses or those working towards those goals, or the OTC investors who play by the rules and look for quality long-term investments. But I’m committed to building a multi-billion-dollar business. I know that in order to do that, we need to create partnerships with major industry players which we’re doing, continue to revise, revamp and improve the product design, architecture, features and functionality, which we’re doing; identify, pursue, negotiate and close accretive, complementary acquisitions, which we’re doing, and ensure that large institutional investors that appreciate the value creation opportunity nFusz represents and who subscribe to our long-term vision, can invest in our company, which means we must be trading on NASDAQ or NYSE. That’s not negotiable. Most people today are unable to purchase our shares through their existing brokerage accounts because those firms will not fulfill their orders for an OTC share traded company. That’s a fact. For that reason alone we need to uplist to NASDAQ. But it’s not the only reason. I’ve said from the very beginning, we are not an OTC company and but for the way we started, we would not have been an OTC company. We would have been a venture-backed tech company getting ready for a NASDAQ or NYSE IPO and the average investor would have never had an opportunity to participate in our stock. Many see this as an opportunity, others don’t or are easily swayed by the noise. The things we’ve done and the things we’re doing are hard. Very hard. But that’s why we’re doing them. We leave the easy things to others. We thrive on hard; we thrive on achieving those things others say can’t be done. And we take pride in making them a reality – our reality. The reality we’re creating for ourselves, our families and our shareholders. This is how it’s done. No one is going to hand it to us; we’ve got to go take it, and some will try to make it even harder than it is. But we’ve been here before, we’ve done this before. And we’re going to do it again. Sure, nothing in life is guaranteed, but we’re putting our own money behind this, along with yours, and we believe in ourselves and those who stand with us, behind us, and along-side us. I never said the path would be without challenges; we’re working through some today. What I have said is that when we come together, we can accomplish those things others perceive as impossible. And together we’ll weather storms and celebrate the wins. Always together.

Rory

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
-- News Section End -->

Top 5 Most Recently Viewed Articles

TOUAX SCA Transitions to Euronext Growth Paris for Growth

Updated Category News Views 154

TOUAX SCA Announces Transfer to Euronext Growth Paris TOUAX SCA has successfully conducted its Combined General Meeting, where shareholders approved a significant decision for the company's future. The approval was for the transfer of TOUAX's listing from the regulated Euronext Paris to the Euronext Growth Paris market. Rationale Behind the Transfer This strategic move is...

Continue Reading
Knowtex's AI Boosts Veterans Affairs Medical Documentation

Updated Category News Views 11

AI's Role in Transforming VA Healthcare Documentation On an overcast Tuesday, Knowtex rolled out a fresh white paper detailing their deployment of clinical AI in the Department of Veterans Affairs. Yeah, another piece of tech jargon, but this one's stirring up some real results where it counts. "Ambient AI, Built for the Nation's Largest Health System" dives into the nuts...

Continue Reading
Key Financial Indicators Influencing Markets This Friday

Updated Category News Views 100

Important Economic Indicators Ahead As traders prepare for a busy financial day, several key economic reports and speeches are set to impact market conditions. Notable among these are the Baker Hughes rig count, a significant address by FOMC member Patrick Harker, and the latest updates from the CFTC on speculative positions. These events are crucial for investors looking...

Continue Reading
Super Micro Computer Faces Price Target Adjustment Ahead

Updated Category News Views 176

Super Micro Computer Inc Price Target Adjustment Super Micro Computer Inc (SMCI) recently had its price target revised by Mizuho, now set at $47, from the previous $40. This adjustment, however, comes while Mizuho maintains a Neutral rating on the stock, indicating careful optimism rather than enthusiasm. Overview of Recent Developments Investors received an update on the...

Continue Reading
Tensions Rise as Wildfires Devastate California’s Communities

Updated Category News Views 253

California Wildfire Crisis: A Political Firestorm California is facing unprecedented wildfires that have engulfed vast areas, leading to immense destruction and loss of life. Amidst this calamity, a clash has erupted between Gov. Gavin Newsom and President-elect Donald Trump. This confrontation has brought their differing approaches to crisis management to the forefront,...

Continue Reading